Effect of Helicobacter pylori treatment on gastroesophageal reflux disease (GERD): meta-analysis of randomized controlled trials

References

• Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005;54:710–17.
   PubMed Web of Science ®Google Scholar
• Camilleri M, Dubois D, Coulie B, Jones M, Kahrilas PJ, Rentz AM, Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol 2005;3:543–5.
   PubMed Web of Science ®Google Scholar
• El-Serag H, Hill C, Jones R. Systematic review: the epidemiology of gastro-esophageal reflux disease in primary care, using the UK general practice database. Aliment Pharmacol Ther 2008;29:470–80.
   PubMedGoogle Scholar
• Fock KM, Talley NJ, Hunt R, Fass R, Nandurkar S, Lam SK, Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease. J Gastroenterol Hepatol 2004;19:357–67.
   PubMedGoogle Scholar
• Wu J. Gastroesophageal reflux disease: an Asian perspective. J Gastroenterol Hepatol 2008:23:1785–93.
   Google Scholar
• Wong BC, Kinoshita Y. Systematic review on epidemiology of gastroesophageal reflux disease in Asia. Clin Gastroenterol Hepatol 2006:4:398–407.
   Google Scholar
• Ehsani MJ, Maleki I, Mohammadzadeh F, Mashayekh A. Epidemiology of gastroesophageal reflux disease in Tehran. Iran J Gastroenterol Hepatol 2007;22:1419–22.
   PubMedGoogle Scholar
• Raghunath A, Hungin AP, Wooff D, Childs S. Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. BMJ 2003;326:737–44.
   PubMed Web of Science ®Google Scholar
• Fock KM, Ang TL. Epidemiology of Helicobacter pylori infection and gastric cancer in Asia. J Gastroenterol Hepatol 2010;25:479–86.
   PubMed Web of Science ®Google Scholar
• El-Serag HB. Time trends of gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol 2007;5:17–26.
   PubMed Web of Science ®Google Scholar
• El-Serag HB, Sonnenberg A. Opposing time trends of peptic ulcer and reflux disease. Gut 1998;43:327–33.
   PubMed Web of Science ®Google Scholar
• Laine L, Sugg J. Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies. Am J Gastroenterol 2002;97:2992–7.
   PubMedGoogle Scholar
• Befrits R, Sjöstedt S, Odman B, Sörngård H, Lindberg G. Curing Helicobacter pylori infection in patients with duodenal ulcer does not provoke gastroesophageal reflux disease. Helicobacter 2000;5:202–5.
   PubMedGoogle Scholar
• Vakil N, Hahn B, McSorley D. Recurrent symptoms and gastro-oesophageal reflux disease in patients with duodenal ulcer treated for Helicobacter pylori infection. Aliment Pharmacol Ther 2000;14:45–51.
   PubMed Web of Science ®Google Scholar
• Moayyedi P, Bardhan C, Young L, Dixon MF, Brown L, Axon AT. Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease. Gastroenterology 2001;121:1120–6.
   PubMed Web of Science ®Google Scholar
• Kuipers EJ, Nelis GF, Klinkenberg-Knol EC, Snel P, Goldfain D, Kolkman JJ, Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial. Gut 2004;53:12–20.
   PubMed Web of Science ®Google Scholar
• Pilotto A, Perri F, Leandro G, Franceschi M; Aging and Acid-Related Disease Study Group. Effect of Helicobacter pylori eradication on the outcome of reflux esophagitis and chronic gastritis in the elderly. A randomized, multicenter, eight-month study. Gerontology 2006;52:99–106.
   PubMedGoogle Scholar
• Harvey RF, Lane JA, Murray LJ, Harvey IM, Donovan JL, Nair P. Randomized controlled trial of the effect of Helicobacter pylori infection and its eradication on heartburn and gastro-oesophageal reflux: Bristol helicobacter project. BMJ 2004;328:1417.
   PubMedGoogle Scholar
• Wu JC, Chan FK, Ching JY, Leung WK, Hui Y, Leong R, Effect of Helicobacter pylori eradication on treatment of gastro-oesophageal reflux disease: a double blind, placebo controlled, randomised trial. Gut 2004;53:174–9.
   PubMed Web of Science ®Google Scholar
• Malfertheiner P, Dent J, Zeijlon L, Sipponen P, Veldhuyzen Van Zanten SJ, Burman CF, Impact of Helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease – results from a randomized trial programme. Aliment Pharmacol Ther 2002;16:1431–42.
   PubMedGoogle Scholar
• Schwizer W, Thumshirn M, Dent J, Guldenschuh I, Menne D, Cathomas G, Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial. Lancet 2001;357:1738–42.
   PubMed Web of Science ®Google Scholar
• Cremonini F, Di Caro S, Delgado-Aros S, Sepulveda A, Gasbarrini G, Gasbarrini A, Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2003;18:279–89.
   PubMedGoogle Scholar
• Raghunath AS, Hungin AP, Wooff D, Childs S. Systematic review: the effect of Helicobacter pylori and its eradication on gastro-oesophageal reflux disease in patients with duodenal ulcers or reflux oesophagitis. Aliment Pharmacol Ther 2004;20:733–44.
   PubMed Web of Science ®Google Scholar
• Yaghoobi M, Farrokhyar F, Yuan Y, Hunt RH. Is there an increased risk of GERD after Helicobacter pylori eradication?: a meta-analysis. Am J Gastroenterol 2010;105:1007–13.
   PubMed Web of Science ®Google Scholar
• Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 1996;17:1–12.
   PubMedGoogle Scholar
• Moayyedi P, Soo S, Deeks J, Forman D, Mason J, Innes M, Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Br Med J 2000;321:659–64.
   PubMed Web of Science ®Google Scholar
• Ofman JJ, Etchason J, Fullerton S, Kahn KL, Soll AH. Management strategies for Helicobacter pylori-seropositive patients with dyspepsia: clinical and economic consequences. Ann Intern Med 1997;126:280–91.
   PubMed Web of Science ®Google Scholar
• Sonnerberg A. Cost-benefit analysis of testing for Helicobacter pylori in dyspeptic subjects. Am J Gastroenterol 1996;91:1773–7.
   PubMedGoogle Scholar
• Lagergren J, Bergstrom R, Lindgren A, Nyre´n O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825–31.
   PubMed Web of Science ®Google Scholar
• Saad AM, Choudhary A, Sathyamurthy A, Hammad HT, Arif M, Bechtold ML, Effect of Helicobacter pylori treatment on GERD: meta-analysis of randomized controlled trials. Gastroenterology 2011;140:S391.
   Google Scholar